Monthly Archives: October 2011

Should Involuntary Treatment for the Mentally Ill Be the Law?

Before I make my exit for the month of November to take part in NaNoWriMo, let me leave you with something meaty to chew on while I’m offline. In 2002, California passed legislation allowing judges to order involuntary treatment for … Continue reading

Posted in Family Support, Health Care Costs, Hospitlization, Mental Illness, Stigma | 9 Comments

More on Bipolar and Socioeconomic Status

Genes can be reset during early life in profoundly different ways depending on whether children grow up in privileged or deprived households, a landmark study has shown. The penalty might be activation of genes that make poorer people more prone … Continue reading

Posted in Bipolar, Manic-depression, Mental Illness, Socioeconomic | Leave a comment

FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder

SILVER SPRING, Md., Oct. 24, 2011 — /PRNewswire-USNewswire/ — The U.S. Food and Drug Administration today approved the first generic versions of Zyprexa (olanzapine tablets) and Zyprexa Zydus (olanzapine orally disintegrating tablets) to treat schizophrenia and bipolar disorder. Read the … Continue reading

Posted in Bipolar, Manic-depression, Medication - Bipolar, Medication - Mental Illness, Mental Illness | 1 Comment

Researchers at the University of Leeds investigating the genetic causes of bipolar disorder have identified two new drugs – one of which has already been found safe in clinical trials – that may be effective in treating the disorder.

Researchers at the University of Leeds investigating the genetic causes of bipolar disorder have identified two new drugs – one of which has already been found safe in clinical trials – that may be effective in treating the disorder. Read … Continue reading

Posted in Bipolar, Manic-depression, Medication - Bipolar, Medication - Mental Illness | 4 Comments

Hypomania or Mania – Which was it?

I’ve had this post in the hopper for a while, and finally decided to publish it after reading another blogger’s post today about what she believes are the differences between Bipolar I and Bipolar II.  Basically, I believe she is … Continue reading

Posted in Uncategorized | 16 Comments

SK biopharmaceuticals Enters into a Licensing Agreement with Premier Chinese Biopharmaceutical Company

SEOUL, Korea, Oct 19, 2011 (BUSINESS WIRE) — South Korean biotech SK biopharmaceuticals announced yesterday that they entered into a research and development agreement with Medicilon, of Shanghai, China, for their novel new small molecule SKL-PSY that is being developed … Continue reading

Posted in Bipolar, Manic-depression, Medication - Mental Illness | 7 Comments

Forest Laboratories, Inc. and Gedeon Richter Announce Positive Phase III Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder

Forest Laboratories, Inc. FRX +0.94% and Gedeon Richter Plc today announced preliminary top-line results from a Phase III clinical trial of cariprazine (RGH-188), an investigational antipsychotic agent, in patients with acute mania associated with bipolar I disorder. Cariprazine is also … Continue reading

Posted in Bipolar, Manic-depression, Medication - Bipolar, Medication - Mental Illness, Mental Illness | 1 Comment

October 2-8 is Mental Illness Awareness Week

While the US has its share of legitimate health crises, none is as widespread or contributes as much to the burden of illness as do mental illnesses. With October 2-8 being Mental Illness Awareness Week, it’s an ideal time to … Continue reading

Posted in Mental Illness | 9 Comments